和邦生物

- 603077

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013 
和邦生物(603077) 利润表
单位:万元
报表日期2023-06-302023-03-312022-12-312022-09-302022-06-30
一、营业总收入409,061.33239,446.821,303,894.801,049,332.48747,902.99
营业收入409,061.33239,446.821,303,894.801,049,332.48747,902.99
二、营业总成本336,892.98191,740.14855,485.01650,425.80437,397.00
营业成本312,492.97176,949.24745,131.54570,029.82386,208.01
营业税金及附加2,913.271,389.1311,402.369,339.536,895.70
销售费用2,728.611,385.955,248.283,742.362,091.39
管理费用17,350.0810,616.1184,496.8762,269.1638,834.84
财务费用-402.80488.892,412.572,600.071,672.21
研发费用1,810.85910.836,793.402,444.851,694.86
资产减值损失----------
公允价值变动收益----------
投资收益4,238.55641.212,183.111,733.331,289.99
其中:对联营企业和合营企业的投资收益3,990.79388.481,966.961,797.231,332.44
汇兑收益----------
三、营业利润72,954.9347,720.62448,115.72404,149.48310,606.50
加:营业外收入0.000.005.841.411.29
减:营业外支出71.3562.24265.34249.40246.73
其中:非流动资产处置损失----------
四、利润总额72,883.5947,658.38447,856.21403,901.49310,361.05
减:所得税费用12,569.409,512.3266,832.3260,464.7046,285.61
五、净利润60,314.1938,146.06381,023.89343,436.80264,075.44
归属于母公司所有者的净利润61,653.1739,656.12380,680.89342,750.17263,463.49
少数股东损益-1,338.98-1,510.06343.01686.63611.95
六、每股收益
基本每股收益(元/股)0.07070.04550.43770.39450.3020
稀释每股收益(元/股)0.07070.04550.43770.39450.3020
七、其他综合收益1,407.47-1,123.234,326.175,314.562,528.21
八、综合收益总额61,721.6637,022.83385,350.07348,751.36266,603.65
归属于母公司所有者的综合收益总额62,391.2538,682.05383,814.46346,684.02265,356.76
归属于少数股东的综合收益总额-669.59-1,659.221,535.612,067.341,246.88
下载全部历史数据到excel中 返回页顶